D.E. Shaw & Co
PIIIW icon

D.E. Shaw & Co’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

D.E. Shaw & Co’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,600
Closed -$9K – 5056
2022
Q3 		$9K Buy
+11,600
New +$8.33K ﹤0.01% 4953

Other funds holding PIIIW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

D.E. Shaw & Co's PIIIW Position: Q4 2022 in Review

D.E. Shaw & Co sold out of P3 Health Partners Inc Warrant (PIIIW) in Q4 2022, closing a stake of 11,600 shares — an estimated $9K sold.

D.E. Shaw & Co first reported a position in PIIIW in Q3 2022 and held it in 1 quarter. The position peaked at $9K in Q3 2022. 29 funds tracked by Wall St. Rank hold PIIIW as of Q4 2022.

  • D.E. Shaw & Co reported no remaining P3 Health Partners Inc Warrant position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 11,600 P3 Health Partners Inc Warrant shares in Q4 2022, an estimated $9K.
  • D.E. Shaw & Co first reported a position in P3 Health Partners Inc Warrant in Q3 2022 and held it in 1 quarter.
  • D.E. Shaw & Co's P3 Health Partners Inc Warrant position peaked at $9K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.